HELX
|
Franklin Genomic Advancements ETF
|
US
|
AMEX
|
HILS
|
Hillstream BioPharma, Inc.
|
US
|
NASDAQ
|
HOOK
|
HOOKIPA Pharma Inc.
|
US
|
NASDAQ
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
HQH
|
H&Q Healthcare Investors
|
US
|
NYSE
|
HTGC
|
Hercules Technology Growth Capital, Inc.
|
US
|
NYSE
|
HTGM
|
HTG Molecular Diagnostics, Inc.
|
US
|
NASDAQ
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
IBB
|
iShares Nasdaq Biotechnology Index Fund
|
US
|
NASDAQ
|
IBBQ
|
Invesco Nasdaq Biotechnology ETF
|
US
|
NASDAQ
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
IDXG
|
Interpace Diagnostics Group, Inc.
|
US
|
NASDAQ
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
IGMS
|
IGM Biosciences, Inc.
|
US
|
NASDAQ
|
ILMN
|
Illumina, Inc.
|
US
|
NASDAQ
|
IMAB
|
I-Mab
|
US
|
NASDAQ
|
IMCR
|
Immunocore Holdings plc
|
US
|
NASDAQ
|